Abstract:ABSTRACT HIV-1 virion production is inefficient in cells derived from mice and other rodents reflecting cell-intrinsic defects to interactions between the HIV-1 auxiliary proteins Tat and Rev and host dependency factors CCNT1 (Cyclin T1) and XPO1 (exportin-1, also known as CRM1), respectively. In human cells, Tat binds CCNT1 to enhance viral RNA transcription and Rev recruits XPO1 to mediate the nuclear export of intron-containing viral RNA. In mouse cells, Tat’s interactions with CCNT1 are inefficient, mapped to a single species-specific residue Y261 instead of C261 in humans. Rev interacts poorly with murine XPO1, mapped to a trio of amino acids T411/V412/S414 instead of P411/M412/F414 in humans. To determine if these discrete species-specific regions of otherwise conserved housekeeping proteins represent viable targets for inhibiting HIV-1 replication in humans, herein, we employed CRISPR/Cas9 to recode the relevant regions of CCNT1 and XPO1 in human CD4+ T cells. While efforts to modify XPO1 were inconclusive, we generated isogenic CCNT1.C261Y cell lines exhibiting remarkable resistance to HIV-1 Tat, exhibiting near total inactivation of viral gene expression for all X4- and R5-tropic HIV-1 strains tested, as well as the more distantly related primate lentiviruses HIV-2 and SIV agm . Induction of viral reactivation using latency reversal agents (LRAs) was also restricted in CCNT1.C261Y cells. These studies validate a minor and naturally occurring, species-specific difference in a conserved human host factor as a compelling potential target for achieving broad-acting cell-intrinsic resistance to HIV’s post-integration phases. IMPORTANCE Unlike humans, mice are unable to support HIV-1 infection. This is due, in part, to a constellation of defined minor, species-specific differences in conserved host proteins needed for viral gene expression. Here, we used precision CRISPR/Cas9 gene editing to engineer a “mousified” version of one such host protein, cyclin T1 (CCNT1), in human T cells. CCNT1 is essential for efficient HIV-1 transcription, making it an intriguing target for gene-based inactivation of virus replication. We show that isogenic cell lines engineered to encode CCNT1 bearing a single mouse-informed amino acid change (tyrosine in place of cysteine at position 261) exhibit potent, durable, and broad-spectrum resistance to HIV-1 and other pathogenic lentiviruses, and with no discernible impact on host cell biology. These results provide proof of concept for targeting CCNT1 in the context of one or more functional HIV-1 cure strategies.

Rev-free HIV-1 gene delivery system for targeting Rev-RRE-Crm1 nucleocytoplasmic RNA transport pathway

The HIV-1 Rev/RRE System is Required for HIV-1 5' UTR Cis Elements to Augment Encapsidation of Heterologous RNA into HIV-1 Viral Particles

A Third-Generation Lentivirus Vector with a Conditional Packaging System

The RRE-Rev Module Has No Effect on the Packaging Efficiency of Cas9 and Gag Proteins into NanoMEDIC Virus-like Particles

Suppression of viral rebound by a Rev-dependent lentiviral particle in SIV-infected rhesus macaques

A New-Generation Stable Inducible Packaging Cell Line for Lentiviral Vectors.

Cessation of HIV-1 Transcription by Inhibiting Regulatory Protein Rev-mediated RNA Transport.

Stable expression of primary human immunodeficiency virus type 1 structural gene products by use of a noncytopathic sindbis virus vector.

HIV-1 Rev interacts with HERV-K RcREs present in the human genome and promotes export of unspliced HERV-K proviral RNA

[HIV-1 Rev and Related Inhibitors].

A stably expressed llama single-domain intrabody targeting Rev displays broad-spectrum anti-HIV activity.

Development of an RNA virus-based episomal vector with artificial aptazyme for gene silencing

Cell-based and Cell-Free Firefly Luciferase Complementation Assay to Quantify Human Immunodeficiency Virus Type 1 Rev-Rev Interaction

Genome Scale Screening Identification of SaCas9/gRNAs for Targeting HIV-1 Provirus and Suppression of HIV-1 Infection

An unusual topological structure of the HIV-1 Rev response element.

Exploiting a rodent cell block for intrinsic resistance to HIV-1 gene expression in human T cells

Efficient gene transfer mediated by HIV-1-based defective lentivector and inhibition of HIV-1 replication

RNA-Binding Domains of Heterologous Viral Proteins Substituted for Basic Residues in the RSV Gag NC Domain Restore Specific Packaging of Genomic RNA

Synthetic gRNA/Cas9 Ribonucleoprotein Inhibits HIV Reactivation and Replication

RNA Helicase MOV10 Functions As a Co-Factor of HIV-1 Rev to Facilitate Rev/RRE-dependent Nuclear Export of Viral Mrnas.

A Self-Deletion Lentiviral Vector to Reduce the Risk of Replication-Competent Virus Formation